Renaud Vidal

Hôpital Européen

Papers

1

Total Citations

5

H-Index

1

About

Renaud Vidal is a leading thoracic surgeon and researcher whose work centers on advancing surgical outcomes for lung cancer patients through rigorous comparative effectiveness research. His primary contributions lie in evaluating minimally invasive surgical approaches—specifically video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery—against traditional open thoracotomy. Using large-scale national databases, Vidal has provided critical evidence on how robotic access impacts postoperative recovery, complication rates, and long-term survival. His landmark 2023 study, drawing from the French Epithor database and analyzing over 38,000 patients, demonstrated that robotic-assisted surgery offers significant advantages over open thoracotomy while remaining comparable to VATS in safety and efficacy. With over 5 citations already, this work is shaping clinical guidelines and surgical decision-making in France and beyond. Vidal’s research is distinguished by its methodological rigor, employing propensity score matching to minimize selection bias in observational data. His findings have direct implications for improving patient outcomes, reducing hospital stays, and guiding the adoption of robotic technology in thoracic surgery—making him a key voice in the ongoing evolution of lung cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Impact of robotic access on outcomes after lung cancer surgery in France: Analysis from the Epithor database
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Hôpital Européen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago